Funding search · EIN 208963321 · New Haven, CT

Alexion Access Foundation

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

21
grants reported
$508.0M
total given
2022–2025
filing years
$22.6M
median grant

Based on grants this organization reported to the IRS for tax years 20222025. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Sign in to analyze this funder’s giving pattern. Free in early access.

21 grants matching “charge · $508.0M

  • $57.5M

    Vials of Strensiq Were Distributed · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $52.0M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $18.1M

    Vials of Soliris Were Distributed T · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.4M

    Vials of Koselugo Were Distributed · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $581,970

    Vials of Kanuma Were Distributed To · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $121,176

    Vials of Voydeya Were Distributed T · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $70.4M

    Vials of Strensiq Were Distributed · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $45.0M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $22.6M

    Vials of Soliris Were Distributed T · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.6M

    Vials of Koselugo Were Distributed · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.1M

    Vials of Kanuma Were Distributed To · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $36.7M

    Vials of Strensiq Were Distributed · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $36.7M

    Vials of Soliris Were Distributed T · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $25.6M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $7.3M

    Vials of Koselugo Were Distributed · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.9M

    Vials of Kanuma Were Distributed To · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $42.4M

    Vials of Strensiq Were Distributed · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $42.2M

    Vials of Soliris Were Distributed T · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $27.9M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $4.8M

    Vials of Koselugo Were Distributed · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.9M

    Vials of Kanuma Were Distributed To · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

Grant history

All 21 reported grants, largest first.

  • $70.4M

    Vials of Strensiq Were Distributed · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $57.5M

    Vials of Strensiq Were Distributed · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $52.0M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $45.0M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $42.4M

    Vials of Strensiq Were Distributed · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $42.2M

    Vials of Soliris Were Distributed T · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $36.7M

    Vials of Strensiq Were Distributed · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $36.7M

    Vials of Soliris Were Distributed T · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $27.9M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $25.6M

    Vials of Ultomiris Were Distributed · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $22.6M

    Vials of Soliris Were Distributed T · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $18.1M

    Vials of Soliris Were Distributed T · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $7.3M

    Vials of Koselugo Were Distributed · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $4.8M

    Vials of Koselugo Were Distributed · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.9M

    Vials of Kanuma Were Distributed To · New Haven, CT · 2023

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.9M

    Vials of Kanuma Were Distributed To · New Haven, CT · 2022

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.6M

    Vials of Koselugo Were Distributed · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.4M

    Vials of Koselugo Were Distributed · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $3.1M

    Vials of Kanuma Were Distributed To · New Haven, CT · 2024

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $581,970

    Vials of Kanuma Were Distributed To · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

  • $121,176

    Vials of Voydeya Were Distributed T · New Haven, CT · 2025

    Provide alexion product at no charge to eligible patients who are unable to afford the prescribed product

Who else funds this kind of work

Same state

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.